loadpatents
name:-0.013099908828735
name:-0.0004279613494873
name:-0.00045299530029297
FABRE; Louis F. Patent Filings

FABRE; Louis F.

Patent Applications and Registrations

Patent applications and USPTO patent grants for FABRE; Louis F..The latest application filed is for "5ht1a agonists for treatment of high cholesterol".

Company Profile
0.0.11
  • FABRE; Louis F. - Houston TX
  • Fabre, Louis F - Houston TX
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
5ht1a Agonists For Treatment Of High Cholesterol
App 20130267533 - FABRE; Louis F. ;   et al.
2013-10-10
GEPIRONE-ER TREATMENT OF MAJOR DEPRESSION IN PATIENTS TAKING NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDs)
App 20130150375 - FABRE; Louis F. ;   et al.
2013-06-13
3-hydroxy Gepirone For The Treatment Of Attention Deficit Disorder And Sexual Dysfunction
App 20090281111 - KRAMER; Stephen J. ;   et al.
2009-11-12
Indolylalkyl Derivatives Of Pyrimidinylpiperazine And Metabolites Thereof For Treatment Of Anxiety, Depression, And Sexual Dysfunction
App 20090281114 - KRAMER; Stephen J. ;   et al.
2009-11-12
Adatanserin And Metabolites Thereof For Treatment Of Attention Deficit Disorder, Anxiety, Depression, Sexual Dysfunction, And Other Disorders
App 20090281112 - KRAMER; Stephen J. ;   et al.
2009-11-12
Nasally Administrable Compositions Of Zolpidem And Methods Of Use
App 20080247961 - KRAMER; Stephen J. ;   et al.
2008-10-09
High-dosage extended-release formulation of gepirone
App 20060099267 - Kramer; Stephen J. ;   et al.
2006-05-11
Extended release compositions
App 20050095286 - Kramer, Stephen J. ;   et al.
2005-05-05
Nasally administrable compositions of zolpidem and methods of use
App 20040241100 - Kramer, Stephen J. ;   et al.
2004-12-02
Methods for treating attention deficit disorder
App 20040002500 - Kramer, Stephen J. ;   et al.
2004-01-01
Use of bioactive metabolites of gepirone for the treatment of psychological disorders
App 20030220346 - Kramer, Stephen J. ;   et al.
2003-11-27

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed